Scarica l'app Stockscreener
1.14
8.80%
-0.11
Dopo l'orario di chiusura:
1.14
Precedente Chiudi:
$1.25
Aprire:
$1.23
Volume 24 ore:
202.57K
Relative Volume:
1.00
Capitalizzazione di mercato:
$51.46M
Reddito:
$80.28M
Utile/perdita netta:
$-38.83M
Rapporto P/E:
-1.3705
EPS:
-0.8318
Flusso di cassa netto:
$-28.67M
1 W Prestazione:
-9.52%
1M Prestazione:
+51.52%
6M Prestazione:
+90.86%
1 anno Prestazione:
-24.50%
Intervallo 1D:
$1.12
$1.25
Intervallo di 1 settimana:
$1.10
$1.29
Portata 52W:
$0.5011
$1.60
Tela Bio Inc Stock (TELA) Company Profile
Nome
Tela Bio Inc
Settore
Industria
Telefono
484-320-2930
Indirizzo
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Compare TELA vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
1.14 | 56.88M | 80.28M | -38.83M | -28.67M | -0.8318 |
ABT
Abbott Laboratories
|
97.50 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.38 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.43 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
42.60 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.15 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-05-31 | Iniziato | Lake Street | Buy |
| 2019-12-03 | Iniziato | Canaccord Genuity | Buy |
| 2019-12-03 | Iniziato | JMP Securities | Mkt Outperform |
| 2019-12-03 | Iniziato | Jefferies | Buy |
| 2019-12-03 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Tela Bio Inc Borsa (TELA) Ultime notizie
TELA Bio gains short-term relief on loan covenants - TipRanks
TELA Bio Price Target Announced at $2.00/Share by Craig-Hallum - Moomoo
TELA Bio Initiates Coverage On Craig-Hallum -- Rating Set to Buy - GuruFocus
TELA Looks 9.3% Undervalued on GF Value™ Amid Leadership Changes and Growth Hopes - GuruFocus
TELA Bio Faces Nasdaq Delisting Over Sub-$1 Share Price - Minichart
TELA Bio Faces Nasdaq Delisting, Plans Reverse Split - TipRanks
TELA Bio (TELA) director buys shares outside trading plan - Stock Titan
TELA Bio Received Notice of Delisting - TradingView
TELA Bio Insider Joseph H. Capper Acquires 75,000 Shares at $1.02-$1.06 Between Sept 14-15, 2026 - Kalkine Media
Tela Bio director Capper acquires $78,442 in company stock By Investing.com - Investing.com Australia
TELA Bio (TELA) Director Joseph Capper Buys 75,000 Shares in Ope - GuruFocus
Tela Bio director Capper acquires $78,442 in company stock - Investing.com
TELA Bio (TELA) director adds to stake in open-market buys - stocktitan.net
Reverse split of up to 1-for-15 heads to a vote at TELA Bio (NASDAQ: TELA) after Nasdaq bid-price warning - Stock Titan
Tela Bio Inc (TELA) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
TELA Bio Inc. (TELA) Edges Higher on Renewed Buying Interest Near Key Support ZoneMoving Average Crossovers - dars.gov.et
Tela Bio CEO Heather Getz buys $8,311 in company stock By Investing.com - Investing.com South Africa
TELA Bio Cuts 41 Jobs as Losses Pressure Cash Position - MyChesCo
Malvern's TELA Bio Cuts Costs 18% and Parts Ways With Longtime COO/CFO Roberto Cuca - BioBuzz
Tela Bio CEO Heather Getz buys $8,311 in company stock - Investing.com
TELA Bio Announces $17 Million Annual Cost Reduction and CFO Change Amid Restructuring - Kalkine Media
TELA Bio Cuts Annual Costs by $17 Million as COO-CFO Departs - citybiz
TELA Bio cuts 20% of workforce to reduce costs by $17M annually - Investing.com India
TELA Looks 52.3% Undervalued on GF Value™ Despite Operational Ch - GuruFocus
TELA Bio Implements Workforce Cuts and Leadership Changes - TipRanks
TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative - GlobeNewswire
TELA Bio (TELA) CEO adds 12,500 shares in August buy - Stock Titan
TELA Bio (TELA) Q2 2026 Earnings Call Transcript - AOL.com
TELA (TELA) Quarter in Focus: The EPS Result Is Below Expectation under the Current Snapshot; Market Response: The Share Price Sheds 1.08% in the Available RecordProduct Revenue Analysis - vinanet.vn
TELA (TELA) Close and Levels: Ends Lower by 1.54% at $0.64 in the Latest Session; Chart Reference: the $0.61 to $0.67 Range Remains in Focus on the DayKAMA Signal - vinanet.vn
SILVERARC CAPITAL MANAGEMENT, LLC Trims TELA Bio Inc (TELA) Stak - GuruFocus
TELA Bio Pulls 2026 Outlook as Sales Fall, Loss Widens - MyChesCo
TELA Bio (TELA) CEO buys 15,000 shares at $0.6978 - Stock Titan
Tela Bio Earnings Call: Growth Meets Execution Risks - TipRanks
TELA Bio (TELA) stake: Nantahala group reports 12.94% ownership of 5.79M shares - Stock Titan
TELA BIO (TELA): SilverArc Capital and Devesh Gandhi disclose 2.14M-share 4.8% stake - Stock Titan
TELA Bio, Inc. (NASDAQ:TELA) Just Reported And Analysts Have Been Cutting Their Estimates - Moomoo
TELA Bio (TELA) Drops 5.86% to $0.68 as Micro-Cap Med-Tech Stock Approaches Critical SupportOvernight Profile - vinanet.vn
Analysts Have Been Trimming Their TELA Bio, Inc. (NASDAQ:TELA) Price Target After Its Latest Report - simplywall.st
TELA Bio, Inc. Revenue Breakdown – NASDAQ:TELA - TradingView
TELA Bio, Inc. Revenue Breakdown – BOATS:TELA - TradingView
TELA Bio, Inc. 2026: Revenue $19.29M, EPS ($0.2) — 10-Q Summary - TradingView
TELA Bio (NASDAQ: TELA) faces going concern doubt amid debt covenants and cash burn - Stock Titan
TELA Bio loss hits USD 9.3M in Q2 2026 - Medical Buyer
TELA BIO (TELA): SilverArc and Devesh Gandhi report 4.8% ownership stake - Stock Titan
TELA Bio, Inc. Stock 12‑Month Price Target Cut to $2.1, Implies 126% Upside - TradingView
Tela Bio earnings missed by $0.03, revenue fell short of estimates - Investing.com Canada
TELA Bio Inc (TELA) (Q2 2026) Earnings Call Highlights: Navigati - GuruFocus
TELA Bio Inc (TELA) (Q2 2026) Earnings Call Highlights: Navigating PRS Headwinds and Strategic ... - Yahoo Finance
TELA Bio, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
TELA Looks 43.6% Undervalued on GF Value™ Despite Operational Un - GuruFocus
Tela Bio Inc Azioni (TELA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Tela Bio Inc Azioni (TELA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Capper Joseph H | Director |
Sep 17 '26 |
Buy |
1.22 |
25,000 |
30,530 |
179,827 |
| Capper Joseph H | Director |
Sep 15 '26 |
Buy |
1.06 |
50,000 |
52,940 |
104,827 |
| Capper Joseph H | Director |
Sep 14 '26 |
Buy |
1.02 |
25,000 |
25,502 |
54,827 |
| Getz Heather C | Chief Executive Officer |
Aug 17 '26 |
Buy |
0.66 |
12,500 |
8,311 |
532,500 |
| Getz Heather C | Chief Executive Officer |
Aug 14 '26 |
Buy |
0.70 |
15,000 |
10,467 |
520,000 |
| EW HEALTHCARE PARTNERS FUND 2, | 10% Owner |
Nov 17 '25 |
Buy |
1.11 |
3,604,000 |
4,000,440 |
7,714,709 |
0.26%
0.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):